Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Metabolic Syndrome Clinical Trials

A listing of Metabolic Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (49) clinical trials

Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions

Background: Autonomic dysfunction, namely increased sympathetic drive and reduced vagal tone, may participate in the pathogenesis and complications of the MetS. Weight loss and aerobic exercise are first-line therapeutic strategies that are known to be beneficial in lowering blood pressure, enhancing insulin action and preventing the development of type 2 ...

Phase N/A

Metabolic Disorders in Polycystic Ovarian Syndrome

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age with a probable prevalence of 5% to 10%. PCOS is characterized by chronic anovulation, menstrual irregularities, evidence of hyperandrogenism (either clinical, manifested as hirsutism, acne, male pattern balding, or biochemical, manifested by elevated serum adrenal and/or ...

Phase N/A

The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance

We are studying patients with body weight change, increased or decreased. Healthy people are the control group. We are recording body weight, body height, and physical exam results. In addition, we are drawing peripheral blood for further biochemical and cytokine assays.

Phase N/A

Pancreatic Islet Function Insulin Sensitivity and Chronic Complications in Pre-Diabetes

We, the investigators at National Taiwan University Hospital, want to compare patients' islet cell function, insulin sensitivity and risk of chronic complications with normal subjects. Moreover, we want to examine whether they are at a higher risk of having metabolic syndrome and to answer whether we should screen the phenotypes ...

Phase N/A

Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism

Primary aldosteronism (PA) is occasionally associated with impaired glucose tolerance. Glucose intolerance, in general metabolic syndrome is caused by suppression of insulin release from the pancreas and suppression of insulin sensitivity of the target tissues. Several studies have suggested that impaired glucose tolerance in primary aldosteronism is due to an ...

Phase N/A

Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress

The metabolic syndrome has been defined as insulin resistance, central obesity, systemic hypertension and dyslipidemia and is associated with increased cardiovascular (CV) risk. Obstructive Sleep Apnea-Hypopnea (OSAH) is also associated with increased CV risk and insulin resistance. Since OSAH is associated with oxidative stress and pro-inflammatory processes, both of which ...

Phase N/A

Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

Specific Aims Although our original interests were condensed in atypicals, the fact that some hospitals discourage the use of atypical antipsychotics for new onset schizophrenia for policy reasons directs us to a study design looking at both types of therapeutics. Coincidently, such a design may provide some hints to the ...

Phase N/A

Collaborative Care for Heart Failure Patients With the Metabolic Syndrome

A striking feature of the Harris County Hospital District heart failure population is that the prevalence of obesity (50.8%) and the metabolic syndrome (48.9%) exceeds that of the general U.S. population. The metabolic syndrome is defined as the presence of 3 out of 5 components: abdominal obesity, elevated blood pressure, ...

Phase N/A